Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 24, 2014

View Archived Issues

Atara Biotherapeutics doses first patient in phase I study of STM-434

[18F]Fludarabine: a highly sensitive and specific radiotracer for lymphoma

Unum Therapeutics launched with Series A funding

Innocrin Pharmaceuticals created as spin-out of Viamet

Forendo Pharma closes financing round to develop a novel therapy for endometriosis

Ablynx reports results from subcutaneous ALX-0061 bioavailability study

Oramed releases topline results from phase IIa study of oral insulin in type 1 diabetes

Regulus Therapeutics' RG-101 demonstrates human proof of concept in HCV infection

U.S. orphan drug status granted to isavuconazonium for invasive candidiasis/candidemia

TapImmune provides update on PolyStart vaccine platform

Profectus BioSciences receives grants to accelerate Ebola vaccine development

Asubio Pharmaceuticals recruits patients in phase II study of SUN-13837

Nicox's shareholders approve acquisition of Aciex Therapeutics

First-in-human results for oral gut-targeted anti-TNF antibody in acute ulcerative colitis

Vertex presents KONDUCT trial results of ivacaftor in patients with CFTR R117H mutations

Researchers at NewLink Genetics disclose new IDO and TDO inhibitors

Bristol-Myers Squibb divulges new NS5B inhibitors for HCV infection

CCX-507 demonstrates safety and efficacy in phase I trials

Sage Therapeutics begins phase IIa trial of SAGE-547 in essential tremor

New O-GlcNAcase inhibitors patented by Merck KGaA

Immunotech Laboratories plans clinical trials of ITV-1 in Ebola virus infection

Novartis synthesizes new agents for bacterial infections

Flatley Discovery designs a new series of CFTR agents for cystic fibrosis

Phase II MenABCWY vaccine results disclosed

Medivation licenses anti-PD-1 antibody pidilizumab from CureTech

FDA extends PDUFA action date for Natpara BLA

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...